Folic Acid Inhibited Vasculogenic Mimicry in Esophageal Cancer Cell Line Eca-109, the One Target Was EphA2

References

• Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou XN, Chen R, et al. Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi. 2019;41(1):19–28.
   PubMedGoogle Scholar
• Mao YS, Gao SG, Wang Q, Shi XT, Li Y, Gao WW, et al. Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database Zhonghua Zhong Liu Za Zhi. 2020;42(3):228–233.
   PubMedGoogle Scholar
• Zhang J, Qiao L, Liang N, Xie J, Luo H, Deng G, Zhang J. Vasculogenic mimicry and tumor metastasis. J Buon. 2016;21(3):533–541.
   PubMed Web of Science ®Google Scholar
• Shi QT, Diao YL, Jin F, Ding ZY. Anti-metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial-mesenchymal transition and angiogenesis. Mol Med Rep. 2018;18(1):131–138. doi:10.3892/mmr.2018.8976
   PubMedGoogle Scholar
• Zhang X, Zhang JG, Zhou HM, Fan GR, Li Q. Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry. J Cancer. 2019;10(25):6327–6340. doi:10.7150/jca.34171
   PubMedGoogle Scholar
• Luo QX, Wang J, Zhao WY, Peng ZZ, Liu XY, Li B, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020;13(1):19–33. doi:10.1186/s13045-020-00858-6
   PubMed Web of Science ®Google Scholar
• Ibiebele TI, Hughes MC, Pandeya N, Zhao Z, Montgomery G, Hayward N, et al. High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian Population. J Nutr Austr Cancer Study. 2011;141(2):274–283. doi:10.3945/jn.110.131235
   PubMed Web of Science ®Google Scholar
• Sharp L, Carsin AE, Cantwell MM, Anderson LA, Murray LJ, Grp FS. Intakes of dietary folate and other b vitamins are associated with risks of esophageal adenocarcinoma, Barrett’s esophagus, and reflux esophagitis. J Nutr. 2013;143(12):1966–1973. doi:10.3945/jn.113.174664
   PubMed Web of Science ®Google Scholar
• Zhao Y, Guo C, Hu H, Zheng L, Ma JL, Jiang L, Zhao E, Li H. Folate intake, serum folate levels and esophageal cancer risk: an overall and dose-response meta-analysis. Oncotarget 2017;8(6):10458–10469. doi:10.18632/oncotarget.14432
   PubMedGoogle Scholar
• Qin TT, Du ML, Du HN, Shu YQ, Wang ML, Zhu LJ. Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials. Sci Rep. 2015;5:12044. doi:10.1038/srep12044
   PubMed Web of Science ®Google Scholar
• Guariento AH, Furtado KS, de Conti A, Campos A, Purgatto E, Carrilho J, et al. Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis. Int J Cancer 2014;135(1):7–18. doi:10.1002/ijc.28642
   PubMedGoogle Scholar
• Wu KN, Platz EA, Willett WC, Selhub J, Fuchs CS, Giovannucci E. A. randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr. 2009;90(6):1623–1631. doi:10.3945/ajcn.2009.28319
   PubMed Web of Science ®Google Scholar
• Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroen Hepat. 2009;21(4):346–349.
   Google Scholar
• Linabery AM, Johnson KJ, Ross JA. Childhood cancer incidence trends in association with US folic acid fortification (1986–2008). Pediatrics. 2012;129(6):1125–1133. doi:10.1542/peds.2011-3418
   PubMed Web of Science ®Google Scholar
• Ayala-Dominguez L, Olmedo-Nieva L, Munoz-Bello JO, Contreras-Paredes A, Manzo-Merino J, Martinez-Ramirez I et al. Mechanisms of vasculogenic mimicry in ovarian cancer. Front Oncol. 2019;9:998.
   PubMedGoogle Scholar
• Zhang J, Deng G, Qiao L, Luo H, Liu Q, Liang N, et al. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. Oncol Lett. 2019;17(1):719. doi:10.3892/ol.2018.9643
   PubMedGoogle Scholar
• Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020;13(1):19. doi:10.1186/s13045-020-00858-6
   PubMed Web of Science ®Google Scholar
• Chai DM, Bao ZQ, Hu JG, Ma L, Feng ZZ, Tao YS. Vasculogenic mimicry and aberrant expression of HIF-lalpha/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma. J Huazhong Univ Sci Technol [Med. Sci.] 2013;33(3):385–391. doi:10.1007/s11596-013-1129-4
   Google Scholar
• Wang F, Li XK, Xu HY, Shan ZZ, Wang T, Yang ZC, et al. N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry. Med Oncol. 2015;32(2):480. doi:10.1007/s12032-014-0480-z
   PubMedGoogle Scholar
• Xu F, Zhong W, Li JC, Zhang SS, Cui JC, Nesland JM, et al. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma. Anticancer Res. 2005;25(4):2943–2950.
   PubMed Web of Science ®Google Scholar
• Kim HS, Won YJ, Shim JH, Kim HJ, Kim BS, Hong HN. Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett. 2019;18(3):3031–3038. doi:10.3892/ol.2019.10677
   PubMedGoogle Scholar
• Syed N, Barbhuiya MA, Pinto SM, Nirujogi RS, Renuse S, Datta KK, et al. Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma. Proteomics. 2015;15(2–3):374–382. doi:10.1002/pmic.201400379
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou H, Zhu YQ, Tie CR. Associations between dietary folate intake and risks of esophageal, gastric and pancreatic cancers: an overall and dose-response meta-analysis. Oncotarget. 2017;8(49):86828–86842. doi:10.18632/oncotarget.18775]
   PubMedGoogle Scholar
• Phan NN, Liu S, Wang CY, Hsu HP, Lai MD, Li CY, et al. Overexpressed gene signature of EPH receptor A/B family in cancer patients-comprehensive analyses from the public high-throughput database. Int J Clin Exp Pathol. 2020;13(5) :1220–42.
   PubMedGoogle Scholar
• Shi H, Yu F, Mao Y, Ju Q, Wu Y, Bai W, et al. EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma. J Thorac Dis. 2018;10(5) :2779–88. doi:10.21037/jtd.2018.04.91
   PubMed Web of Science ®Google Scholar
• Li P, Liu X, Dong Z, M, Ling ZQ. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma. Oncotarget. 2015;6(35) :38151–65. doi:10.18632/oncotarget.5832
   PubMedGoogle Scholar
• Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin HL, Wang L, et al. HIF-1alpha induces VE-cadherin expression and modulates Vasculogenic mimicry in esophageal carcinoma cells. World J Gastroenterol. 2014;20(47) :17894–904. doi:10.3748/wjg.v20.i47.17894
   PubMed Web of Science ®Google Scholar
• Delgado-Bellido D, Bueno-Galera C, Lopez-Jimenez L, Garcia-Diaz A, Oliver FJ. Endothelial phosphatase VE-PTP participates in Vasculogenic mimicry by preventing autophagic degradation of VE-cadherin. Front Oncol. 2020;10:18.
   PubMedGoogle Scholar
• Li XZ, Xue YX, Liu XB, Zheng J, Shen SY, Yang CQ, et al. ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma. J Exp Clin Cancer Res. 2019;38:68.
   PubMed Web of Science ®Google Scholar
• Ge H, Luo H. Overview of advances in Vasculogenic mimicry - a potential target for tumor therapy. Cancer Manage Res. 2018;10:2429–37. doi:10.2147/CMAR.S164675
   PubMed Web of Science ®Google Scholar
• Hernandez de la Cruz ON, Lopez-Gonzalez JS, Garcia-Vazquez R, Salinas-Vera YM, Muniz-Lino MA, Aguilar-Cazares D, et al. Regulation networks driving Vasculogenic mimicry in solid tumors. Front Oncol. 2019;9:1419.
   PubMedGoogle Scholar
• Zhang JG, Zhou HM, Zhang X, Mu W, Hu JN, Liu GL, et al. Hypoxic induction of Vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 alpha, RhoA/ROCK and Rac1/PAK signaling. BMC Cancer. 2020;20(1) :32. doi:10.1186/s12885-019-6501-8
   PubMed Web of Science ®Google Scholar
• Mitra D, Bhattacharyya S, Alam N, Sen S, Mitra S, Mandal S, et al. Phosphorylation of EphA2 receptor and Vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast. Breast Cancer Res Treat. 2020;179(2) :359–70. doi:10.1007/s10549-019-05482-8
   PubMedGoogle Scholar
• Cheng L, Wang Q, Tao X, Qin Y, Wu Q, Zheng D, et al. FOXM 1 induces Vasculogenic mimicry in esophageal cancer through beta-catenin/Tcf4 signaling. Diagn Pathol. 2020;15(1) :14. doi:10.1186/s13000-020-00929-9
   PubMedGoogle Scholar